Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of an AI-Based Tool for Identifying Responders and Stratifying Risks in Ulinastatin Treatment in Cardiac Surgery: A Multicenter Real-world Study

NCT07583290 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT07583290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07583290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of an AI-Based Tool for Identifying Responders and Stratifying Risks in Ulinastatin Treatment in Cardiac Surgery: A Multicenter Real-world Study
Lead sponsor
Beijing Anzhen Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2018
Completion date
March 31, 2027
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgical procedures, cardiopulmonary bypass, multiple organ dysfunction syndrome, postoperative complications, systemic inflammatory response syndrome